Vor Biopharma Ownership | Who Owns Vor Biopharma?

Vor Biopharma Ownership Summary

Vor Biopharma is owned by 90.94% institutional investors, 3.07% insiders, and 5.99% retail investors. Vanguard group is the largest institutional shareholder, holding 11.53% of VOR shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.10% of its assets in Vor Biopharma shares.

VOR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vor Biopharma	90.94%	3.07%	5.99%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	770.25K	11.53%	$10.07M
Blackrock funding, inc. /de	465.64K	6.97%	$6.09M
Ubs group	292.12K	4.37%	$3.82M
Geode capital management	185.81K	2.78%	$2.43M
Goldman sachs group	145.64K	2.18%	$1.90M
Jane street group	91.81K	1.37%	$1.20M
Johnson & johnson	53.73K	0.80%	$702.82K
Blackrock	497.70K	0.73%	$497.70K
Morgan stanley	28.46K	0.43%	$372.30K
Millennium management	261.84K	0.38%	$290.64K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Johnson & johnson	53.73K	0.13%	$702.82K
Chung wu investment group	8.30K	0.09%	$108.56K
China universal asset management	2.75K	0.00%	$35.92K
Ubs group	292.12K	0.00%	$3.82M
Acadian asset management	86.69K	0.00%	$95.00K
Geode capital management	185.81K	0.00%	$2.43M
Jane street group	91.81K	0.00%	$1.20M
Goldman sachs group	145.64K	0.00%	$1.90M
Fortitude family office	31.00	0.00%	$553.00
Vanguard group	770.25K	0.00%	$10.07M

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	770.25K	0.00%	665.06K
Blackrock funding, inc. /de	465.64K	0.00%	431.11K
Ubs group	292.12K	0.00%	216.21K
Geode capital management	185.81K	0.00%	158.42K
Goldman sachs group	145.64K	0.00%	129.85K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-39.65M
Paradigm biocapital advisors lp	-	-	-6.46M
5am venture management	-	-	-6.36M
Hudson bay capital management lp	-	-	-2.47M
Fmr	-	-	-2.09M

New Positions

Holder	Shares	% Assets	Change	Value
Sei investments	17.60K	-	17.60K	$17.60K
Aqr capital management	11.20K	-	11.20K	$11.20K
Chung wu investment group	8.30K	0.09%	8.30K	$108.56K
Citigroup	6.34K	-	6.34K	$82.93K
China universal asset management	2.75K	0.00%	2.75K	$35.92K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-6.00
Point72 (difc)	-26.00
Nisa investment advisors	-45.00
Citadel advisors	-100.00
Smartleaf asset management	-102.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	32	-30.43%	6,076,499	61.43%	90	2.87%	20	17.65%	3	-86.96%
Sep 30, 2025	45	9.76%	3,764,067	-93.40%	56	2.72%	17	-10.53%	22	100.00%
Jun 30, 2025	41	-2.38%	57,027,241	7.15%	45	2.50%	21	16.67%	11	-35.29%
Mar 31, 2025	44	-16.98%	60,090,600	-1.40%	48	0.61%	18	-10.00%	18	12.50%
Dec 31, 2024	52	-5.45%	60,931,305	27.38%	88	1.82%	20	11.11%	16	-11.11%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	2.12M	3.10%	-
Fidelity Select Biotechnology	1.54M	2.83%	-836.00K
State Street® SPDR® S&P® Biotech ETF	932.40K	1.72%	14.28K
Fidelity Growth Compy Commingled Pl S	1.96M	1.57%	-207.80K
Vanguard Total Stock Mkt Idx Inv	475.88K	1.15%	-
Vanguard US Total Market Shares ETF	1.39M	1.11%	-
Fidelity Growth Company Fund	1.27M	1.02%	-140.15K
Fidelity Capital Appreciation	610.40K	0.49%	-
Fidelity VIP Growth Initial	618.39K	0.49%	-
Vanguard Institutional Extnd Mkt Idx Tr	177.91K	0.43%	-

Recent Insider Transactions

Date	Name	Activity	Value
Apr 15, 2026	RA CAPITAL MANAGEMENT, L.P.	Sell	$858.84K
Apr 14, 2026	RA CAPITAL MANAGEMENT, L.P.	Sell	$2.46M
Apr 13, 2026	RA CAPITAL MANAGEMENT, L.P.	Sell	$8.57M
Apr 08, 2026	RA CAPITAL MANAGEMENT, L.P.	Sell	$5.76M
Apr 08, 2026	RA CAPITAL MANAGEMENT, L.P.	Sell	$2.21M

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	12
2026 Q1	-	-
2025 Q4	-	56
2025 Q3	-	14
2025 Q2	-	-

VOR Ownership FAQ

Who Owns Vor Biopharma?

Vor Biopharma shareholders are primarily institutional investors at 90.94%, followed by 3.07% insiders and 5.99% retail investors. The average institutional ownership in Vor Biopharma's industry, Biotech Stocks , is 382.13%, which Vor Biopharma falls below.

Who owns the most shares of Vor Biopharma?

Vor Biopharma’s largest shareholders are Vanguard group (770.25K shares, 11.53%), Blackrock funding, inc. /de (465.64K shares, 6.97%), and Ubs group (292.12K shares, 4.37%). Together, they hold 22.87% of Vor Biopharma’s total shares outstanding.

Does Blackrock own Vor Biopharma?

Yes, BlackRock owns 0.73% of Vor Biopharma, totaling 497.7K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 497.7K$. In the last quarter, BlackRock decreased its holdings by -1.75M shares, a -77.86% change.

Who is Vor Biopharma’s biggest shareholder by percentage of total assets invested?

Johnson & johnson is Vor Biopharma’s biggest shareholder by percentage of total assets invested, with 0.13% of its assets in 53.73K Vor Biopharma shares, valued at 702.82K$.

Who is the top mutual fund holder of Vor Biopharma shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Vor Biopharma shares, with 3.10% of its total shares outstanding invested in 2.12M Vor Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools